CORONARY STENT THAT RELEASE MEDICAMENTUOUS COMPOSITION TO PREVENT AND TREAT RESTENOSIS AND FABRICATION PROCESS

摘要

A stent is described that releases medicamentous composition to prevent and treat restenosis and the fabrication process that comprehends between 10,0 to 500,0 Ug/cm2 of the surface of the stent coated with rapamycin (sirolismus) or analogous and between 0,01 to 20,0 Ug/mm2 of the surface of the stent coated with paclitaxel or analogous.